SC
AMGN icon

Scotia Capital’s Amgen AMGN Stock Holding History

Scotia Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,000
Closed -$3.25M – 680
2015
Q4 		$3.25M Sell
20,000
-31,500
-61% -$4.95M 0.07% 193
2015
Q3 		$7.12M Buy
51,500
+31,500
+158% +$4.97M 0.16% 100
2015
Q2 		$3.07M Buy
+20,000
New +$3.2M 0.06% 218

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Scotia Capital's AMGN Position: Q2 2026 in Review

Scotia Capital reduced its Amgen (AMGN) stake by 25% in Q2 2026, selling an estimated $2.84M and leaving 25,458 shares worth $9.22M. The position accounts for 0.03% of the portfolio, ranked #234.

Scotia Capital first reported a position in AMGN in Q3 2013 and has held it in 51 quarters since. The position peaked at $16.5M in Q3 2024. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Scotia Capital held 25,458 shares of Amgen worth $9.22M as of Q2 2026.
  • Scotia Capital sold 8,293 Amgen shares in Q2 2026, an estimated $2.84M.
  • Amgen made up 0.03% of Scotia Capital's portfolio in Q2 2026, its #234 holding.
  • Scotia Capital first reported a position in Amgen in Q3 2013 and has held it in 51 quarters since.
  • Scotia Capital's Amgen position peaked at $16.5M in Q3 2024.
  • 3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.